Bruker Completes $37.5M Acquisition of Three Varian Product Lines from Agilent

The lines, which Agilent divested in order to receive European Commission approval for its $1.5 billion acquisition of Varian, will form the core of Bruker's new Chemical Analysis Division.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.